DOI:
10.1055/s-00000054
Pharmacopsychiatry
LinksClose Window
References
Daniel DG, Zimbroff DL, Potkin SG et al.
Ziprasidone 80 mg/day and 160 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 6-week placebo-controlled trial. Ziprasidone Study Group. Neuropsychopharmacol 1999;
20: 491-505
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.